Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 6;24(3):102152.
doi: 10.1016/j.isci.2021.102152. eCollection 2021 Mar 19.

Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism

Affiliations

Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism

Helene J Bustad et al. iScience. .

Abstract

Porphobilinogen deaminase (PBGD), the third enzyme in the heme biosynthesis, catalyzes the sequential coupling of four porphobilinogen (PBG) molecules into a heme precursor. Mutations in PBGD are associated with acute intermittent porphyria (AIP), a rare metabolic disorder. We used Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS) to demonstrate that wild-type PBGD and AIP-associated mutant R167W both existed as holoenzymes (Eholo) covalently attached to the dipyrromethane cofactor, and three intermediate complexes, ES, ES2, and ES3, where S represents PBG. In contrast, only ES2 was detected in AIP-associated mutant R173W, indicating that the formation of ES3 is inhibited. The R173W crystal structure in the ES2-state revealed major rearrangements of the loops around the active site, compared to wild-type PBGD in the Eholo-state. These results contribute to elucidating the structural pathogenesis of two common AIP-associated mutations and reveal the important structural role of Arg173 in the polypyrrole elongation mechanism.

Keywords: Biochemistry; Biological Sciences; Proteomics; Structural Biology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

None
Graphical abstract
Figure 1
Figure 1
Crystal structure of hPBGD wt-Eholo and schematic representation of the polypyrrole elongation mechanism (A) Overall representation of the crystal structure of wt-hPBGD (PDB: 7AAJ), providing the expected holoenzyme (Eholo) with three separate domains (domain 1 is presented in red, domain 2 in light brown, and domain 3 in green). The bound dipyrromethane (DPM) cofactor is shown in a brown stick representation. (B) Schematic representation of the general understanding of the mechanism of a single step in the polypyrrole elongation. (C) The polypyrrole elongation catalyzed by PBGD. PBGD with attached DPM (Eholo) subsequently binds four porphobilinogen (PBG) substrates (S), and generates the enzyme intermediates ES, ES2, ES3, and ES4. The linear product, hydroxymethylbilane (HMB), is released by hydrolysis and cyclized by the next enzyme in the heme biosynthesis. The sidechains of the substrates, acetate (CH2CO2H) and propionate (CH2CH2CO2H) are denoted Ac and Pr, respectively. Figure 1C is modified from (Jordan and Woodcock, 1991).
Figure 2
Figure 2
High-resolution mass spectrometry of hPBGD enzymes The ESI FT-ICR mass spectra were measured at denaturing conditions with 5 μM protein. (A) Broadband mass spectrum of wt-hPBGD with numbers denoting different protein ion-charge states. A wide charge state distribution from 18 + to 45+ is consistent with the protein being fully unfolded. (B) Charge-deconvoluted mass spectrum showing peaks representing different enzyme-intermediates in wt-hPBGD. (C) and (D) Charge-deconvoluted mass spectra of the hPBGD mutants R167W and R173W, respectively. The peaks representing different enzyme-intermediates are assigned. See also Figures S1–S3, and Tables S1 and S2.
Figure 3
Figure 3
The crystal structure of hPBGD wt-Eholo and R173W-ES2 (A) Overall cartoon representation of wt-Eholo (gray; PDB: 7AAJ) and mutant R173W-ES2 (blue; PDB: 7AAK) superimposed. DPM cofactor with C1 and C2 units of wt-Eholo is shown in brown and elongation product of R173W-ES2 including S1 and S2 units is shown in green. The mutated residue studied here, R173W, is shown as sticks. The cofactor-binding loop and cofactor are rearranged (red arrow) in the structure, allowing incoming substrate pyrroles (S1 and S2) substitute C1 and C2 at equal positions as in the Eholo. (B) The active-site loop (residues 57–74) orientation in wt-ES2 (PDB: 5M6R; dark gray (Pluta et al., 2018)) is compared to the loop orientation in R173W-ES2 (red). Formed ⍺21 helixes are labeled. Close-up also shows the movement of the cofactor-binding loop (orange; residues 257–263), and the elongation product in the R173W mutant. The position of cofactor-binding Cys261 has been indicated with labels C261-Eholo and C261-ES2 for wt-Eholo and R173W-ES2 structures, respectively. Glycerol (GOL) partially filling the solvent cavity under the cofactor-binding loop in the R173W-ES2 structure is shown as sticks (yellow). See also Figures S4 and S5.
Figure 4
Figure 4
Electron density for the structural features Calculated 2mFo-DFc-electron density for (A) the active-site loop in R173W-ES2, (B) bound cofactor in wt-Eholo and (C) the polypyrrole chain in R173W-ES2. Electron density is contoured with sigma level of 1.0.
Figure 5
Figure 5
Stick representation of the active site The image shows active site interactions of (A) our wt-Eholo (side chains gray and substrate brown), and (B) R173W-ES2 (side chains blue and substrate green) superimposed with wt-ES2 (PDB: 5M6R; side chains dark gray and substrate pink (Pluta et al., 2018)). Incoming PBG units in the ES2 intermediates substitute C1 and C2 at equal positions as in the Eholo. Interactions are described in detail in Table 2.
Figure 6
Figure 6
Schematic view of the interactions between the pyrrole rings and the hPBGD protein in the crystal structures of wt-Eholo and R173W-ES2 mutant (A) The hydrogen bond interactions of the DPM cofactor with the wt-hPBGD residues in the active site. (B) The interactions between the pyrrole chain intermediate as seen in the crystal structure of the R173W-hPBGD mutant. Side chain H-bond interactions (blue), H-bond interactions to main chain carbonyl oxygen (green) and H-bond interactions to nitrogen (red).

References

    1. Anderson P.M., Desnick R.J. Purification and properties of uroporphyrinogen I synthase from human erythrocytes. Identification of stable enzyme-substrate intermediates. J. Biol. Chem. 1980;255:1993–1999. - PubMed
    1. Andersson C., Floderus Y., Wikberg A., Lithner F. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. Scand. J. Clin. Lab Invest. 2000;60:643–648. - PubMed
    1. Awan S.J., Siligardi G., Shoolingin-Jordan P.M., Warren M.J. Reconstitution of the holoenzyme form of Escherichia coli porphobilinogen deaminase from apoenzyme with porphobilinogen and preuroporphyrinogen: a study using circular dichroism spectroscopy. Biochemistry. 1997;36:9273–9282. - PubMed
    1. Azim N., Deery E., Warren M.J., Wolfenden B.A., Erskine P., Cooper J.B., Coker A., Wood S.P., Akhtar M. Structural evidence for the partially oxidized dipyrromethene and dipyrromethanone forms of the cofactor of porphobilinogen deaminase: structures of the Bacillus megaterium enzyme at near-atomic resolution. Acta Crystallographica. Section D Biol. Crystallogr. 2014;70:744–751. - PMC - PubMed
    1. Berry A., Jordan P.M., Seehra J.S. The isolation and characterization of catalytically competent porphobilinogen deaminase-intermediate complexes. FEBS Lett. 1981;129:220–224. - PubMed

LinkOut - more resources